Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1990-07-09
1992-11-24
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
544212, 544238, 544295, 544333, 544357, 544360, 544362, 544364, 544365, 546116, 546256, 546258, 546283, 546310, A61K 31495, C07D40310, C07D40110
Patent
active
051661489
ABSTRACT:
There are provided novel 1,4-dihydropyridine compounds possessing both calcium agonist and alpha.sub.1 -antagonist activity useful for treating congestive heart failure, pharmaceutical compositions containing them and methods of using these compounds to treat congestive heart failure in a mammal.
REFERENCES:
patent: 4248873 (1981-02-01), Bossert et al.
patent: 4532248 (1985-07-01), Franckowiak et al.
patent: 4537881 (1985-08-01), Heiker et al.
patent: 4868181 (1989-09-01), Johnson et al.
patent: 4886819 (1989-12-01), Ashimori et al.
patent: 4937242 (1990-06-01), Matsui et al.
M. Schram, et al. Nature 303:535 (1983).
M. Schram, et al. Arzneim-Forsch 33:1268 (1983).
P. Erne et al., Biochem. Biophys. Res. Commun. 118:842 (1984).
Aldrich Paul E.
Earl Richard A.
Ma Philip
Ivy C. Warren
The Du Pont Merck Pharmaceutical Company
Turnipseed James H.
LandOfFree
2-amino-1,4-dihydropyridine derivatives with calcium agonist and does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-amino-1,4-dihydropyridine derivatives with calcium agonist and, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-amino-1,4-dihydropyridine derivatives with calcium agonist and will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-921773